TRPM7 knockdown reduced the expression of all metastasis-associated markers, suggesting that TRPM7 might be a new therapeutic target for attenuating HNSCC metastasis and chemotherapeutic resistance. Here, TRPM7 is linked to head and neck squamous cell carcinoma.